Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vi-CRM197 vaccine in adults, children, and infants for typhoid fever
NCT01229176Phase 2Completed
- Sponsor
- Novartis
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of TyphiBEV in typhoid fever, sponsored by Novartis. Started Mar 2011; status: completed.
02
Drugs
TyphiBEV
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT01229176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229176.